TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Navamedic ASA
Closing information (x1000 EUR)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
44,862
|
45,549
|
36,303 |
| Financial expenses |
4,111
|
1,275
|
1,203 |
| Earnings before taxes |
-137
|
964
|
4,038 |
| Total assets |
39,463
|
46,644
|
36,363 |
| Current assets |
16,883
|
18,693
|
23,136 |
| Current liabilities |
11,887
|
16,839
|
11,976 |
| Equity capital |
18,291
|
19,785
|
19,923 |
| - share capital |
1,103
|
1,142
|
1,211 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
46.3%
|
42.4%
|
54.8% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-0.3%
|
2.1%
|
11.1% |
| Return on assets (ROA) |
10.1%
|
4.8%
|
14.4% |
| Current ratio |
142.0%
|
111.0%
|
193.2% |
| Return on equity (ROE) |
-0.7%
|
4.9%
|
20.3% |
| Change turnover |
1,641
|
11,553
|
9,851 |
| Change turnover % |
4%
|
34%
|
37% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.